Inventor · disambiguated record
Hilma Van Der Horst
Also filed as: VAN DER HORST HILMA
5 granted patents·5 pending applications·26 citations·filing 2018–2022
78Inventor score
Top patents by PatentIndex Score
10 records- 0195US11396553B2Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereofGENMAB HOLDING B V·Filed 2021·Granted Jul 26, 2022·8 cites·23 claims
- 0294US11512137B2Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereofGENMAB HOLDING B V·Filed 2020·Granted Nov 29, 2022·10 cites·10 claims
- 0394US11034772B2Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereofGENMAB HOLDING B V·Filed 2020·Granted Jun 15, 2021·7 cites·20 claims
- 0480US2024117064A1Bispecific anti-cd37 antibodies, monoclonal anti-cd37 antibodies and methods of use thereofGENMAB HOLDING B V·Filed 2022·Application pending·0 cites
- 0577US12448459B2Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereofGENMAB HOLDING B V·Filed 2021·Granted Oct 21, 2025·0 cites·23 claims
- 0672US12275797B2Anti-CD37 antibodies and anti-CD20 antibodies, compositions and methods of use thereofGENMAB HOLDING B V·Filed 2019·Granted Apr 15, 2025·1 cites·18 claims
- 0764US2020270359A1Bispecific anti-cd37 antibodies, monoclonal anti-cd37 antibodies and methods of use thereofGENMAB HOLDING BV·Filed 2018·Application pending·0 cites
- 0859US2023399414A1Bispecific anti-cd37 antibodies, monoclonal anti-cd37 antibodies and methods of use thereofGENMAB HOLDING B V·Filed 2022·Application pending·0 cites
- 0953US2023293680A1A composition of anti-dr5 antibodies and an immunomodulatory imide drug for use in treating multiple myelomaGENMAB BV·Filed 2021·Application pending·0 cites
- 1046US2024252635A1Pharmaceutical compositions comprising bispecific anti-cd37 antibodiesGENMAB HOLDING B V·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hilma Van Der Horst files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →